Preventing post-cataract endophthalmitis

Article

Intracameral antibiotic therapy helps prevent endophthalmitis after cataract surgery, while topical antibiotic therapy does not, according to a literature review conducted by researchers from Denmark and published online in Acta Ophthalmologica.

Intracameral antibiotic therapy helps prevent endophthalmitis after cataract surgery, while topical antibiotic therapy does not, according to a literature review conducted by researchers from Denmark and published online in Acta Ophthalmologica.

The researchers conducted a systematic literature review of four databases: MEDLINE, CINAHL, Cochrane Library, and EMBASE, to find studies relating to the prophylactic effect of intracameral antibiotics on the rate of endophthalmitis after cataract surgery. They found 17 observational studies and one randomized trial. For the effect of topical antibiotics on endophthalmitis rates, they found one observational study and one randomized trial.

When intracameral antibiotics were used, endophthalmitis occurred on average in 1 of 2,855 surgeries. Endophthalmitis occurred in 1 of 485 surgeries when intracameral antibiotics were not used. Using intracameral antibiotics reduced the relative risk of endophthalmitis to 0.12 (0.08; 0.18, p <0.00001).

The researchers reported that the use of intracameral antibiotic administration of cefazolin, cefuroxime, and moxifloxacin produced high-to-moderate quality evidence for a marked reduction in the risk of endophthalmitis. No such effect was found with topical antibiotics or intracameral vancomycin.

  

“In conclusion, we found strong and consistent evidence that intracameral cefuroxime administered at the conclusion of cataract surgery significantly lowers the risk of endophthalmitis,” the researchers wrote. “We could not find any evidence that topical antibiotic treatment after cataract surgery lowers the risk of endophthalmitis. As there is no documented effect of topical antibiotic treatment and its use may be associated with concern for selection of resistant bacterial strains, we cannot recommend using it.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.